📇 Rhumatologue · FREJUS CEDEX · (83) · Libéral
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Praticien-chercheur
19 articles scientifiques publiés — formation continue solide
Disponibilité géographique
2 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
118.8 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
5
5 articles ont été cités au moins 5fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
888
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
10
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
4
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Centre Hospitalier Intercommunal de Fréjus Saint-Raphaël
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Secondary Bacterial Infections in Patients with Atopic Dermatitis or Other Common Dermatoses
2024ArticleAmerican Journal of Clinical Dermatology
Erythema Migrans Caused by <i>Borrelia spielmanii</i>, France
2023ArticleEmerging Infectious Diseases
Anti‐BP180 IgG antibody ELISA values correlate with adverse pregnancy outcomes in pemphigoid gestationis
2023ArticleJournal of the European Academy of Dermatology and Venereology
A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms : Is it time to reconsider the current contraindication ?
2021ArticlePLoS Neglected Tropical Diseases
Nocardia takedensis: a newly recognized pathogen responsible for skin and soft tissue infections
2020ArticleAnnals of Clinical Microbiology and Antimicrobials
Measles Transmission in a Fully Vaccinated Closed Cohort
2019ArticlePediatric Infectious Disease Journal
Fatal infection caused by Capnocytophaga canimorsus
2017ArticleThe Lancet Infectious Diseases
Dermatological spectrum of hand, foot and mouth disease from classical to generalized exanthema.
2014ArticlePediatric Infectious Disease Journal
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CABINET PRIVE DU DR PASCAL DEL GIUDICE
CHI DE FREJUS SAINT RAPHAEL 240 AVENUE DE SAINT LAMBERT BP 110, 83608 FREJUS CEDEX
CHI DE FREJUS SAINT RAPHAEL
240 AV DE SAINT LAMBERT CS 90110, 83608 FREJUS CEDEX
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
The Pediatric infectious disease journal · 2014
PLoS neglected tropical diseases · 2021
BackgroundOral ivermectin is a safe broad spectrum anthelminthic used for treating several neglected tropical diseases (NTDs). Currently, ivermectin use is contraindicated in children weighing less than 15 kg, restricting access to this drug for the treatment of NTDs. Here we provide an updated systematic review of the literature and we conducted an individual-level patient data (IPD) meta-analysis describing the safety of ivermectin in children weighing less than 15 kg.Methodology/Principal findingsA systematic review was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) for IPD guidelines by searching MEDLINE via PubMed, Web of Science, Ovid Embase, LILACS, Cochrane Database of Systematic Reviews, TOXLINE for all clinical trials, case series, case reports, and database entries for reports on the use of ivermectin in children weighing less than 15 kg that were published between 1 January 1980 to 25 October 2019. The protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO): CRD42017056515. A total of 3,730 publications were identified, 97 were selected for potential inclusion, but only 17 sources describing 15 studies met the minimum criteria which consisted of known weights of children less than 15 kg linked to possible adverse events, and provided comprehensive IPD. A total of 1,088 children weighing less than 15 kg were administered oral ivermectin for one of the following indications: scabies, mass drug administration for scabies control, crusted scabies, cutaneous larva migrans, myiasis, pthiriasis, strongyloidiasis, trichuriasis, and parasitic disease of unknown origin. Overall a total of 1.4% (15/1,088) of children experienced 18 adverse events all of which were mild and self-limiting. No serious adverse events were reported.Conclusions/SignificanceExisting limited data suggest that oral ivermectin in children weighing less than 15 kilograms is safe. Data from well-designed clinical trials are needed to provide further assurance.
AIDS (London, England) · 2010
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
JAAD case reports · 2023 · Case Reports
Del Giudice P, Reverte M
The New England journal of medicine · 2019 · Letter
Hubiche T, Del Giudice P
The American journal of tropical medicine and hygiene · 2018 · Case Reports
Del Giudice P, Hubiche T, Marie Roger P
Acta dermato-venereologica · 2018 · Letter
Del Giudice P, Hubiche T
Journal of dermatological science · 2017 · Case Reports
Alkhalifah A, Chiaverini C, Del Giudice P, Supsrisunjai C, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene · 2012 · Journal Article
Pomares C, Despierres L, del Giudice P, Delaunay P, et al.
Dermatology (Basel, Switzerland) · 2012 · Journal Article
Fouéré S, Dion PL, Casin I, Zouakh-Agsous M, et al.
The American journal of tropical medicine and hygiene · 2008 · Journal Article
Clyti E, Deligny C, Nacher M, Del Giudice P, et al.
Emerging infectious diseases · 2023 · Journal Article
Del Giudice P, Fribourg A, Roudiere L, Gillon J, et al.
PLoS neglected tropical diseases · 2021 · Journal Article
Jittamala P, Monteiro W, Smit MR, Pedrique B, et al.
The Pediatric infectious disease journal · 2020 · Case Reports
Del Giudice P, Hubiche T
International journal of dermatology · 2019 · Letter
Del Giudice P
Acta dermato-venereologica · 2019 · Journal Article
Taquin H, Hubiche T, Roudière L, Fribourg A, et al.
AIDS (London, England) · 2010 · Journal Article
Abgrall S, Del Giudice P, Melica G, Costagliola D, et al.
PLoS neglected tropical diseases · 2021 · Journal Article
Jittamala P, Monteiro W, Smit MR, Pedrique B, et al.
Presse medicale (Paris, France : 1983) · 2012 · English Abstract
Del Giudice P, Tattevin P, Etienne J
Dermatology (Basel, Switzerland) · 2010 · Case Reports
Hakimi S, Rivière S, Del Giudice P, Dereure J, et al.
PLoS neglected tropical diseases · 2021 · Journal Article
Jittamala P, Monteiro W, Smit MR, Pedrique B, et al.
The Pediatric infectious disease journal · 2019 · Case Reports
Hubiche T, Brazier C, Vabret A, Reynaud S, et al.
The Pediatric infectious disease journal · 2014 · Journal Article
Hubiche T, Schuffenecker I, Boralevi F, Léauté-Labrèze C, et al.
The Pediatric infectious disease journal · 2013 · Journal Article
Courjon J, Hubiche T, Phan A, Tristan A, et al.